Board of Directors

Pivotal role in high quality investment deals in GenesisCare and Genscript.

Top pedigree investments, IPOs and trade sales over 19 years with Andera Partners.

Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.

Founded and led Arrow Therapeutics Ltd to $150 million acquisition by AstraZeneca.

Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).